Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Andrew L, Schilb"'
Autor:
Da Sun, Wenyu Sun, Song-Qi Gao, Jonathan Lehrer, Amirreza Naderi, Cheng Wei, Sangjoon Lee, Andrew L. Schilb, Josef Scheidt, Ryan C. Hall, Elias I. Traboulsi, Krzysztof Palczewski, Zheng-Rong Lu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 29, Iss , Pp 823-835 (2022)
Stargardt disease (STGD) is the most common form of inherited retinal genetic disorders and is often caused by mutations in ABCA4. Gene therapy has the promise to effectively treat monogenic retinal disorders. However, clinically approved adeno-assoc
Externí odkaz:
https://doaj.org/article/cb04137658994b97a05895718c16a714
Autor:
Andrew L. Schilb, Josef H. Scheidt, Amita M. Vaidya, Zhanhu Sun, Da Sun, Sangjoon Lee, Zheng-Rong Lu
Publikováno v:
Pharmaceuticals, Vol 14, Iss 10, p 1016 (2021)
Nucleic acids are promising for a variety of therapies, such as cancer therapy and the gene therapy of genetic disorders. The therapeutic efficacy of nucleic acids is reliant on the ability of their efficient delivery to the cytosol of the target cel
Externí odkaz:
https://doaj.org/article/05d85eeca6e14b68ab0a1dd323b7a976
Autor:
Amita M. Vaidya, Ryan C. W. Hall, Ramamurthy Gopalakrishnan, Zheng-Rong Lu, Nadia Ayat, Zhanhu Sun, Da Sun, Laura M Hertz, Josef H Scheidt, Andrew L Schilb
Publikováno v:
Pharmaceutical Research. 38:1405-1418
To investigate the effectiveness of targeted ECO/miR-200c in modulating tumor microenvironment and treating triple negative breast cancer (TNBC) using non-invasive magnetic resonance molecular imaging (MRMI) of extradomain B fibronectin (EDB-FN) with
Autor:
Andrew L Schilb, Wenyu Sun, Josef H Scheidt, Amirreza Naderi, Songqi Gao, Krzysztof Palczewski, Da Sun, Sang-Joon Lee, Zheng-Rong Lu, Timothy S. Kern, Cheng Wei
Publikováno v:
J Control Release
It is still a challenge to develop gene replacement therapy for retinal disorders caused by mutations in large genes, such as Stargardt disease (STGD). STGD is caused by mutations in ABCA4 gene. Previously, we have developed an effective non-viral ge
Publikováno v:
Cancer Communications
Autor:
Da Sun, Andrew L Schilb, Ryan C. W. Hall, Michelle Yin, Zheng-Rong Lu, Josef H Scheidt, X. Liu, Nadia Ayat, Zhanhu Sun, Amita M. Vaidya
Publikováno v:
Nucleic Acid Ther
Nanoparticle based siRNA formulations often suffer from aggregation and loss of function during storage. We in this study report a frozen targeted RGD-polyethylene glycol (PEG)-ECO/siβ3 nanoparticle formulation with a prolonged shelf life and preser
Autor:
Andrew L, Schilb, Nadia R, Ayat, Amita M, Vaidya, Laura M, Hertz, Ryan C, Hall, Josef H, Scheidt, Da, Sun, Zhanhu, Sun, Ramamurthy, Gopalakrishnan, Zheng-Rong, Lu
Publikováno v:
Pharmaceutical research. 38(8)
To investigate the effectiveness of targeted ECO/miR-200c in modulating tumor microenvironment and treating triple negative breast cancer (TNBC) using non-invasive magnetic resonance molecular imaging (MRMI) of extradomain B fibronectin (EDB-FN) with
Autor:
Da Sun, Zheng Han, Rui Xin, Hongfa Jiang, Amirreza Naderi, Zhanhu Sun, Nadia Ayat, Zheng-Rong Lu, Andrew L Schilb, Peter Qiao, Amita M. Vaidya
Publikováno v:
Bioconjugate Chemistry
CRISPR/Cas9 system is a promising approach for gene editing in gene therapy. Effective gene editing requires safe and efficient delivery of CRISPR/Cas9 system in target cells. Several new multifunctional pH-sensitive amino lipids were designed and sy
Autor:
Zhanhu Sun, Zheng-Rong Lu, Amita M. Vaidya, Nadia Ayat, Da Sun, Hannah Gilmore, Xujie Liu, Siyuan He, Victoria Qian, Josef H Scheidt, Hongfa Jiang, Andrew L Schilb, William P. Schiemann
Publikováno v:
Bioconjugate chemistry. 30(3)
Long non-coding RNAs (lncRs), by virtue of their versatility and multilevel gene regulation, have emerged as attractive pharmacological targets for treating heterogenous and complex malignancies like triple-negative breast cancer (TNBC). Despite mult